medmix AG (SWX: MEDX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
10.02
-0.02 (-0.20%)
Sep 4, 2024, 3:26 PM CET

medmix AG Statistics

Total Valuation

medmix AG has a market cap or net worth of CHF 409.52 million. The enterprise value is 642.42 million.

Market Cap 409.52M
Enterprise Value 642.42M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date Feb 26, 2025
Ex-Dividend Date Apr 26, 2024

Share Statistics

medmix AG has 40.79 million shares outstanding.

Shares Outstanding 40.79M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.18%
Owned by Institutions (%) 28.80%
Float 23.99M

Valuation Ratios

PE Ratio n/a
Forward PE 16.00
PS Ratio 0.88
PB Ratio 0.89
P/FCF Ratio 16.85
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.80, with an EV/FCF ratio of 26.44.

EV / Earnings -356.90
EV / Sales 1.34
EV / EBITDA 8.80
EV / EBIT 38.70
EV / FCF 26.44

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 77.34.

Current Ratio 1.48
Quick Ratio 1.03
Debt / Equity 77.34
Debt / EBITDA 4.98
Debt / FCF 14.98
Interest Coverage 1.39

Financial Efficiency

Return on equity (ROE) is -0.21% and return on invested capital (ROIC) is 1.27%.

Return on Equity (ROE) -0.21%
Return on Assets (ROA) 1.03%
Return on Capital (ROIC) 1.27%
Revenue Per Employee 177,996
Profits Per Employee -668
Employee Count 2,695
Asset Turnover 0.48
Inventory Turnover 3.40

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.97% in the last 52 weeks. The beta is 0.79, so medmix AG's price volatility has been lower than the market average.

Beta (5Y) 0.79
52-Week Price Change -61.97%
50-Day Moving Average 12.13
200-Day Moving Average 15.53
Relative Strength Index (RSI) 32.29
Average Volume (20 Days) 114,162

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, medmix AG had revenue of CHF 479.70 million and -1.80 million in losses. Loss per share was -0.04.

Revenue 479.70M
Gross Profit 156.30M
Operating Income 16.60M
Pretax Income 500,000
Net Income -1.80M
EBITDA 63.50M
EBIT 16.60M
Loss Per Share -0.04

Balance Sheet

The company has 140.70 million in cash and 363.90 million in debt, giving a net cash position of -223.20 million or -5.47 per share.

Cash & Cash Equivalents 140.70M
Total Debt 363.90M
Net Cash -223.20M
Net Cash Per Share -5.47
Equity (Book Value) 470.50M
Book Value Per Share 11.30
Working Capital 105.60M

Cash Flow

In the last 12 months, operating cash flow was 69.30 million and capital expenditures -45.00 million, giving a free cash flow of 24.30 million.

Operating Cash Flow 69.30M
Capital Expenditures -45.00M
Free Cash Flow 24.30M
FCF Per Share 0.60

Margins

Gross margin is 32.58%, with operating and profit margins of 3.46% and -0.38%.

Gross Margin 32.58%
Operating Margin 3.46%
Pretax Margin 0.10%
Profit Margin -0.38%
EBITDA Margin 13.24%
EBIT Margin 3.46%
FCF Margin 5.07%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 4.98%.

Dividend Per Share 0.50
Dividend Yield 4.98%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 4.98%
Earnings Yield -0.42%
FCF Yield 5.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a